|
2. Tie-2, G-CSF, and leptin as promising diagnostic biomarkers for endometrial cancerLuka Roškar, Teja Klančič, Tamara Knific, Tea Lanišnik-Rižner, Špela Smrkolj, 2021, original scientific article Keywords: endometrial cancer, angiogenesis, biomarkers, angiogenic factors, Tie-2, G-CSF, leptin Full text (file, 3,21 MB) This document has more files! More...
|
3. Altered profile of E1-S transporters in endometrial cancerRenata Pavlič, Suzana Vidic, Maja Anko, Tamara Knific, Tomaž Büdefeld, Kristina Marton, Maša Sinreih, Stefan Poschner, Walter Jäger, Snježana Frković-Grazio, Tea Lanišnik-Rižner, 2021, original scientific article Keywords: endometrial cancer, intracrinology, organic anion-transporting polypeptides, estrone-sulphate (E1-S), sulfatase pathway, E1-S transporters, ATP-binding cassette transporters, organic solute transporters Full text (file, 4,88 MB) This document has more files! More...
|
4. Diagnostic and therapeutic values of angiogenic factors in endometrial cancerLuka Roškar, Irena Roškar, Tea Lanišnik-Rižner, Špela Smrkolj, 2022, review article Keywords: endometrial cancer, angiogenesis, biomarkers, angiogenic factors, anti-angiogenic therapy Full text (file, 1,07 MB) This document has more files! More...
|
5. Overview of immune checkpoint inhibitors in gynecological cancer treatmentBoštjan Pirš, Erik Škof, Vladimir Smrkolj, Špela Smrkolj, 2022, review article Keywords: immune check-point inhibitor, biomarker, endometrial cancer, ovarian cancer, uterine cervical cancer, vulvar cancer, treatment response prediction Full text (file, 731,71 KB) This document has more files! More...
|
6. Physiological concentrations of Cimicifuga racemosa extract do not affect expression of genes involved in estrogen biosynthesis and action in endometrial and ovarian cell linesMaša Sinreih, Klara Gregorič, Kristina Gajser, Tea Lanišnik-Rižner, 2022, original scientific article Keywords: endometrial cancer, Cimicifuga racemosa, ovarian cancer, steroid transporters Full text (file, 5,66 MB) This document has more files! More...
|